SCHEMBL5698709

SCHEMBL5698709

CS(=O)(=O)c1ccc(-c2nc(-c3ccc(F)cc3)oc2-c2ccc(F)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.75
PTGS1 P23219 4/20 0.75
FAAH O00519 1/20 0.58
KCNH2 Q12809 1/20 0.58
MAPK14 Q16539 3/20 0.57
MAPK11 Q15759 2/20 0.56
MAPK13 O15264 1/20 0.56
GCGR P47871 1/20 0.56
MAPK12 P53778 1/20 0.56
ALDH1A1 P00352 1/20 0.53
ALOX5 P09917 1/20 0.53
CSNK1A1 P48729 1/20 0.53
CSNK1D P48730 1/20 0.53
CSNK1E P49674 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CSNK1A1L Q8N752 1/20 0.53
USP1 O94782 1/20 0.51
USP19 O94966 1/20 0.51
UCHL3 P15374 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8553156 0.95 PTGS2 (0.68) PTGS2PTGS1FAAHKCNH2MAPK14
SCHEMBL213979 0.95 PTGS2 (0.68) PTGS2PTGS1FAAHKCNH2MAPK14
SCHEMBL7504194 0.95 PTGS2 (0.68) PTGS2PTGS1FAAHKCNH2MAPK14
SCHEMBL19953600 0.86 PTGS2 (0.75) PTGS2PTGS1
SCHEMBL216233 0.86 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL7503718 0.86 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL1002033 0.84 PTGS2 (0.58) PTGS2PTGS1FAAHKCNH2MAPK14
SCHEMBL214222 0.82 PTGS2 (0.70) PTGS2PTGS1
SCHEMBL7506192 0.81 PTGS2 (0.67) PTGS2PTGS1MAPK14MAPK11MAPK13
SCHEMBL7505884 0.81 PTGS2 (0.67) PTGS2PTGS1MAPK14MAPK11MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed